Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Disambiguating the optic nerve from the surrounding cerebrospinal fluid: Application to MS-related atrophy.
Lipopolysaccharide directly stimulates Th17 differentiation in vitro modulating phosphorylation of RelB and NF-κB1.
Plasma levels of endothelial and B-cell-derived microparticles are restored by fingolimod treatment in multiple sclerosis patients.
Identification and Preclinical Pharmacology of BMS-986104: A Differentiated S1P1 Receptor Modulator in Clinical Trials.
Immunity and inflammation in neurodegenerative diseases.
Neurodegeneration: From Multiple Sclerosis to Alzheimer's Disease.
Targeting interleukin-6 in inflammatory autoimmune diseases and cancers.
Antigenic epitopes of MAP2694 homologous to T-cell receptor gamma-chain are highly recognized in multiple sclerosis Sardinian patients.
Magnetic resonance spectroscopic findings of chronic lesions in two subtypes of multiple sclerosis: primary progressive versus relapsing remitting.
Imaging multiple sclerosis outside the brain.
Experimental mouse model of optic neuritis with inflammatory demyelination produced by passive transfer of neuromyelitis optica-immunoglobulin G.
Predictors of quality of life in patients with relapsing-remitting multiple sclerosis: A 2-year longitudinal study.
Glial cells express nuclear nrf2 after fumarate treatment for multiple sclerosis and psoriasis.
Induction of endogenous Type I interferon within the central nervous system plays a protective role in experimental autoimmune encephalomyelitis.
Gamma-aminobutyric acid receptor agonists, aquaporin-4, and neuromyelitis optica: a potential link.
Deletion of caspase-8 in mouse myeloid cells blocks microglia pro-inflammatory activation and confers protection in MPTP neurodegeneration model.
Substrate stiffness of endothelial cells directs LFA-1/ICAM-1 interaction: A physical trigger of immune-related diseases?
Role of glial 14-3-3 gamma protein in autoimmune demyelination.
Levels and actions of neuroactive steroids in the nervous system under physiological and pathological conditions: Sex-specific features.
The Role of Geranylgeranyltransferase I-Mediated Protein Prenylation in the Brain.
Genetic loci for Epstein-Barr virus nuclear antigen-1 are associated with risk of multiple sclerosis.
Ocular Toxicities of MEK inhibitors and other targeted therapies.
Cerebral venous thrombosis in a patient with clinically isolated spinal cord syndrome.
Satellite glial cells in dorsal root ganglia are activated in experimental autoimmune encephalomyelitis.
Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study.
Pages
« first
‹ previous
…
539
540
541
542
543
544
545
546
547
…
next ›
last »